Massachusetts Healthcare Journal: Press Releases

Browse our comprehensive archive of press releases by date.
Select a specific day to access all press releases published on Massachusetts Healthcare Journal.

Press releases published on November 2, 2026

Nov. 2, 2026

FED Fitness Opens Pre-Sale for Dual-Angle SH1 and SH1 Pro Smith Machines

Indeterminate EIN Presswire

Nov. 2, 2026

Joined Bio Marks One Year Since Platform Launch with More Than 10,000 New Participants and a Year of Rapid Growth

Indeterminate EIN Presswire

Nov. 2, 2026

Pharmacies Rethink the Workflow: Conveyor Systems Emerge as the Backbone of Modern Pharmaceutical Handling

Indeterminate EIN Presswire

Nov. 2, 2026

Staritas Names Kathy Ford Chief Product Officer to Accelerate Product Innovation

Indeterminate EIN Presswire

Nov. 2, 2026

J-Star Holding Co., Ltd. Receives Shareholder Approval for Capital Restructuring and Reinforces Strategic Focus on U.S. Growth

Indeterminate GlobeNewswire

Nov. 2, 2026

Vireo Growth Inc. Receives Federal DEA Registrations for Florida Medical Cannabis Dispensaries

Indeterminate GlobeNewswire

Nov. 2, 2026

Nuvectis Pharma to Report Third Quarter 2026 Financial Results on November 4, 2026

Indeterminate GlobeNewswire

Nov. 2, 2026

Dianthus Therapeutics Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

Indeterminate GlobeNewswire

Nov. 2, 2026

Zentalis Pharmaceuticals Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

Indeterminate GlobeNewswire

Nov. 2, 2026

Claire’s Place Foundation Marks 15 Years of Helping Families Stay Beside Loved Ones with Cystic Fibrosis

Indeterminate GlobeNewswire

Nov. 2, 2026

Opus Genetics Reports Inducement Grants under NASDAQ Listing Rule 5635(c)(4)

Indeterminate GlobeNewswire

Nov. 2, 2026

MiNK Therapeutics to Report Third Quarter 2026 Results and Outline Progress in Randomized Clinical Development and Scalable iNKT Cell Therapy

Indeterminate GlobeNewswire

Nov. 2, 2026

DBV Technologies to Participate in Upcoming November Investor Conferences

Indeterminate GlobeNewswire

Nov. 2, 2026

DBV Technologies participera aux prochaines Conférences Investisseurs en novembre

Indeterminate GlobeNewswire

Nov. 2, 2026

Olema Oncology to Participate in Upcoming Investor Conferences

Indeterminate GlobeNewswire

Nov. 2, 2026

Recursion Reports Third Quarter 2026 Financial Results and Extends Cash Runway; Highlights Positive Clinical Data in REC-4881 and REC-1245, Sanofi Development Candidate Option and Appointment of Fred Hassan as Chair

Indeterminate GlobeNewswire

Nov. 2, 2026

Inspire Medical Systems, Inc. Announces Third Quarter 2026 Financial Results

Indeterminate GlobeNewswire

Nov. 2, 2026

Intuitive Appoints Aaron Martin to its Board of Directors

Indeterminate GlobeNewswire

Nov. 2, 2026

Medline announces participation in the 2026 Jefferies Global Healthcare Conference

Indeterminate GlobeNewswire

Nov. 2, 2026

SI-BONE, Inc. Reports Financial Results for the Third Quarter 2026 and Reaffirms 2026 Revenue Guidance

Indeterminate GlobeNewswire